Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of August, 2023

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches, the first of which was completed on October 26, 2022. In respect of each of the two tranches, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the second tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on June 13, 2023, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended August 31, 2023, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:




Ordinary Shares



Volume Weighted

Average Price Paid

per Ordinary Share


Highest Price Paid


Lowest Price Paid

August 1, 2023

   36,328    223.77p    226.00p    221.50p

August 2, 2023

   36,705    215.97p    220.00p    212.00p

August 3, 2023

   36,450    212.34p    216.00p    208.00p

August 4, 2023

   38,496    208.41p    213.50p    205.50p

August 7, 2023

   38,879    205.71p    210.50p    202.00p

August 8, 2023

   36,252    204.26p    206.50p    202.00p

August 9, 2023

   38,139    205.35p    208.00p    203.00p

August 10, 2023

   38,729    205.66p    208.00p    204.00p

August 11, 2023

   36,425    202.42p    205.50p    200.00p

August 14, 2023

   34,241    198.75p    202.00p    196.40p

August 15, 2023

   34,400    196.51p    198.00p    194.00p

August 16, 2023

   35,616    198.88p    200.00p    196.20p

August 17, 2023

   33,370    194.66p    196.40p    193.00p

August 18, 2023

   32,487    188.42p    193.20p    183.20p

August 21, 2023

   33,425    184.31p    187.20p    181.80p

August 22, 2023

   32,721    183.65p    184.40p    182.60p

August 23, 2023

   32,441    186.66p    189.00p    184.80p

August 24, 2023

   32,058    189.25p    192.00p    187.60p

August 25, 2023

   32,187    188.02p    189.20p    184.60p

August 29, 2023

   31,857    191.53p    194.40p    188.40p

August 30, 2023

   33,759    195.99p    196.40p    194.80p

August 31, 2023

   35,198    196.61p    198.60p    194.40p

During the month ended August 31, 2023, the Company repurchased an aggregate of 770,163 Ordinary Shares. As of August 31, 2023, the Company’s issued share capital was 289,468,159 shares, 14,158,321 of which were held in treasury, resulting in total voting rights in the Company of 275,309,838 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

August 1, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4855102.html

August 2, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4856592.html

August 3, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4858205.html

August 4, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4859562.html

August 7, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4861022.html

August 8, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4862449.html

August 9, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4863840.html

August 10, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4865358.html

August 11, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4866721.html

August 14, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4868159.html

August 15, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4869540.html

August 16, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4870908.html

August 17, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4872386.html

August 18, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4873704.html

August 21, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4875227.html

August 22, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4876653.html

August 23, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4877913.html

August 24, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4879331.html

August 25, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4880597.html

August 29, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4882508.html

August 30, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4883970.html

August 31, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4885624.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: September 6, 2023   By:  

/s/ Daphne Zohar

    Name: Daphne Zohar
    Title:   Chief Executive Officer